Breaking News Instant updates and real-time market news.

ACLS

Axcelis

$20.06 /

+0.5 (+2.56%)

, AEIS

Advanced Energy

$47.93 /

+1.2 (+2.57%)

08:02
03/12/19
03/12
08:02
03/12/19
08:02

Susquehanna to hold a conference

8th Annual Technology Conference will be held in New York on March 12.

ACLS

Axcelis

$20.06 /

+0.5 (+2.56%)

AEIS

Advanced Energy

$47.93 /

+1.2 (+2.57%)

ASML

ASML

$180.99 /

+2.19 (+1.22%)

BKI

Black Knight

$52.10 /

+0.28 (+0.54%)

CEVA

Ceva

$28.08 /

+0.46 (+1.67%)

CHKP

Check Point

$120.05 /

+1.09 (+0.92%)

DESP

Despegar.com

$17.42 /

+0.06 (+0.35%)

DLX

Deluxe

$42.54 /

+0.37 (+0.88%)

GLW

Corning

$34.19 /

+0.4 (+1.18%)

ICHR

Ichor Holdings

$20.58 /

+1.38 (+7.19%)

KLIC

Kulicke & Soffa

$23.35 /

+0.645 (+2.84%)

LASR

nLight

$21.22 /

+0.69 (+3.36%)

LSCC

Lattice Semiconductor

$13.00 /

+0.45 (+3.59%)

MXL

MaxLinear

$25.06 /

+0.52 (+2.12%)

OLED

Universal Display

$152.12 /

+4.67 (+3.17%)

SIMO

Silicon Motion

$42.47 /

+2.22 (+5.52%)

TSEM

Tower Semiconductor

$17.09 /

+0.51 (+3.08%)

  • 12

    Mar

  • 12

    Mar

  • 13

    Mar

  • 13

    Mar

  • 13

    Mar

  • 13

    Mar

  • 13

    Mar

  • 25

    Mar

  • 16

    Apr

  • 17

    Apr

  • 28

    May

ACLS Axcelis
$20.06 /

+0.5 (+2.56%)

02/08/19 Craig-Hallum
Axcelis downgraded to Hold from Buy at Craig-Hallum
02/08/19 Benchmark
Axcelis upgraded to Buy from Hold at Benchmark
01/28/19 B. Riley FBR
Axcelis upgraded to Buy from Neutral at B. Riley FBR
11/02/18 Benchmark
Axcelis downgraded to Hold from Buy at Benchmark
AEIS Advanced Energy
$47.93 /

+1.2 (+2.57%)

07/09/18 Susquehanna
Advanced Energy price target lowered to $68 from $80 at Susquehanna
07/05/18
On The Fly: Top five analyst upgrades
07/05/18
Advanced Energy upgraded upgraded to Outperform on valuation at Raymond James
07/05/18 Raymond James
Advanced Energy upgraded to Outperform from Market Perform at Raymond James
ASML ASML
$180.99 /

+2.19 (+1.22%)

02/13/19 RBC Capital
RBC Capital sees Google data centers news as positive for AMD, Nvidia
02/04/19 Citi
Texas Instruments, TSMC, Lam among Citi's top global Semi picks for 2019
02/04/19 Liberum
ASML upgraded to Buy from Hold at Liberum
01/28/19 Goldman Sachs
Logitech upgraded to Buy from Neutral at Goldman Sachs
BKI Black Knight
$52.10 /

+0.28 (+0.54%)

11/30/18 BTIG
Ocwen initiated with a Neutral at BTIG
11/29/18 Susquehanna
Black Knight initiated with a Positive at Susquehanna
11/20/18 Barclays
Black Knight investment in D&B raises some questions, says Barclays
11/20/18 Wedbush
Black Knight price target lowered to $50 from $55 at Wedbush
CEVA Ceva
$28.08 /

+0.46 (+1.67%)

02/14/19 Canaccord
Ceva price target lowered to $35 from $41 at Canaccord
02/14/19 Northland
Ceva downgraded to Market Perform from Outperform at Northland
11/28/18
Ceva and Tempow partner for True Wireless Stereo Bluetooth earbuds
08/08/18 Roth Capital
Ceva price target lowered to $35 from $44 at Roth Capital
CHKP Check Point
$120.05 /

+1.09 (+0.92%)

01/30/19 Jefferies
Check Point price target raised to $140 from $137 at Jefferies
01/16/19 Stifel
Checks show firewall spending remains 'robust,' says Stifel
12/10/18 Guggenheim
Check Point initiated with a Neutral at Guggenheim
10/25/18 BMO Capital
Check Point price target lowered to $120 from $130 at BMO Capital
DESP Despegar.com
$17.42 /

+0.06 (+0.35%)

08/17/18 Morgan Stanley
Despegar.com price target lowered to $22 from $24 at Morgan Stanley
08/17/18 Itau BBA
Despegar.com downgraded to Underperform from Market Perform at Itau BBA
06/26/18 KeyBanc
Despegar.com price target lowered to $30 from $40 at KeyBanc
DLX Deluxe
$42.54 /

+0.37 (+0.88%)

10/12/18 Buckingham
Deluxe initiated with a Neutral at Buckingham
03/26/18 Sidoti
Deluxe reinitiated with a Buy at Sidoti
GLW Corning
$34.19 /

+0.4 (+1.18%)

11/29/18 Citi
Citi consumer electronics survey positive for Corning, negative for GoPro
11/14/18 Guggenheim
Guggenheim sees 5% iPhone drop next year, downgrades Apple to Neutral
09/20/18 Argus
Corning price target raised to $42 from $36 at Argus
09/14/18
On The Fly: Top five analyst upgrades
ICHR Ichor Holdings
$20.58 /

+1.38 (+7.19%)

03/08/19
Fly Intel: Top five analyst initiations
03/07/19 DA Davidson
Ichor Holdings initiated with a Buy at DA Davidson
02/07/19 Needham
Ichor Holdings price target raised to $27 from $22 at Needham
12/21/18 Needham
Ichor Holdings initiated with a Buy at Needham
KLIC Kulicke & Soffa
$23.35 /

+0.645 (+2.84%)

11/20/18 DA Davidson
Kulicke & Soffa price target lowered to $32 from $35 at DA Davidson
11/20/18 Craig-Hallum
Kulicke & Soffa initiated with a Buy at Craig-Hallum
09/10/18 Stifel
Stifel maintains near-term outlook on WFE despite KLA-Tencor comments
07/11/18 B. Riley FBR
Kulicke & Soffa price target raised to $38 from $36 at B. Riley FBR
LASR nLight
$21.22 /

+0.69 (+3.36%)

02/27/19 Northcoast
January Laser Industry survey shows continued mixed outlook, says Northcoast
02/21/19 Benchmark
nLight valuation not justified by expected growth, says Benchmark
02/21/19 Stifel
nLight weakness would present a buying opportunity, says Stifel
02/08/19
Fly Intel: Top five analyst initiations
LSCC Lattice Semiconductor
$13.00 /

+0.45 (+3.59%)

02/28/19
Rosenblatt bullish on Lattice Semiconductor, initiates coverage with a Buy
02/28/19 Rosenblatt
Lattice Semiconductor initiated with a Buy at Rosenblatt
02/13/19 Jefferies
Lattice Semiconductor price target raised to $10.50 from $8.50 at Jefferies
02/13/19 Susquehanna
Lattice Semiconductor upgraded to Positive at Susquehanna
MXL MaxLinear
$25.06 /

+0.52 (+2.12%)

01/04/19 JPMorgan
MaxLinear initiated with a Neutral at JPMorgan
10/25/18 Susquehanna
MaxLinear downgraded to Neutral at Susquehanna
10/25/18 Susquehanna
MaxLinear downgraded to Neutral from Positive at Susquehanna
10/18/18 Stifel
Stifel lowers analog and IoT semiconductor estimates on broad-based slowdown
OLED Universal Display
$152.12 /

+4.67 (+3.17%)

02/26/19 Roth Capital
Universal Display price target raised to $172 from $128 at Roth Capital
02/22/19 Needham
Universal Display price target raised to $140 from $105 at Needham
01/23/19 Oppenheimer
Universal Display price target lowered to $115 from $120 at Oppenheimer
01/04/19 Needham
Universal Display price target lowered to $105 from $125 at Needham
SIMO Silicon Motion
$42.47 /

+2.22 (+5.52%)

02/13/19 KeyBanc
KeyBanc anticipates NAND shortages by year-end
01/18/19 BofA
Silicon Motion upgraded to Buy from Underperform at BofA/Merrill
01/17/19 Needham
Silicon Motion price target lowered to $50 from $58 at Needham
01/09/19 Roth Capital
Silicon Motion price target lowered to $45 from $50 at Roth Capital
TSEM Tower Semiconductor
$17.09 /

+0.51 (+3.08%)

10/30/18 Craig-Hallum
TowerJazz price target lowered to $21 from $29 at Craig-Hallum
10/30/18 Loop Capital
TowerJazz price target lowered to $28 from $36 at Loop Capital
10/09/18 Jefferies
TowerJazz initiated with a Buy at Jefferies
08/28/18 Standpoint Research
TowerJazz upgraded to Buy from Hold at Standpoint Research

TODAY'S FREE FLY STORIES

Earnings
Charles River raises FY20 adj. EPS view to $7.05-$7.35 from $6.75-$7.10 » 07:13
08/05/20
08/05
07:13
08/05/20
07:13
CRL

Charles River

$203.78 /

-3.69 (-1.78%)

Consensus $6.91. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRL Charles River
$203.78 /

-3.69 (-1.78%)

CRL Charles River
$203.78 /

-3.69 (-1.78%)

07/21/20 UBS
Charles River price target raised to $236 from $200 at UBS
07/01/20 BofA
Charles River upgraded to Buy from Neutral at BofA
07/01/20 BofA
Charles River upgraded to Buy from Neutral at BofA
05/26/20 Argus
Charles River price target raised to $190 from $150 at Argus
CRL Charles River
$203.78 /

-3.69 (-1.78%)

Hot Stocks
Bausch Health resolves Canadian securities class action » 07:13
08/05/20
08/05
07:13
08/05/20
07:13
BHC

Bausch Health

$18.99 /

-0.13 (-0.68%)

Bausch Health announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

06/17/20 H.C. Wainwright
Bausch Health price target raised to $64 from $50 at H.C. Wainwright
06/03/20 Jefferies
Duobrii could become a key revenue driver for Bausch Health, says Jefferies
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Bausch Health initiated with a Buy at Citi
BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

Earnings
Starwood Property reports Q2 core EPS 43c, consensus 42c » 07:12
08/05/20
08/05
07:12
08/05/20
07:12
STWD

Starwood Property

$14.93 /

+0.03 (+0.20%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

05/05/20 B. Riley FBR
Starwood Property price target lowered to $18 from $27 at B. Riley FBR
04/27/20 Credit Suisse
Starwood Property price target lowered to $16 from $26 at Credit Suisse
12/02/19 Wells Fargo
Starwood Property initiated with an Outperform at Wells Fargo
08/14/19 Raymond James
Starwood Property price target raised to $27 from $24 at Raymond James
STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

Recommendations
Enphase Energy price target raised to $90 from $70 at Roth Capital » 07:12
08/05/20
08/05
07:12
08/05/20
07:12
ENPH

Enphase Energy

$69.05 /

+7.84 (+12.81%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENPH Enphase Energy
$69.05 /

+7.84 (+12.81%)

ENPH Enphase Energy
$69.05 /

+7.84 (+12.81%)

07/27/20 Roth Capital
Enphase Energy price target raised to $70 from $60 at Roth Capital
07/24/20
Fly Intel: Top five analyst initiations
07/24/20 JMP Securities
Enphase Energy initiated with a Market Perform at JMP Securities
06/29/20 Needham
Enphase Energy initiated with a Buy at Needham
ENPH Enphase Energy
$69.05 /

+7.84 (+12.81%)

ENPH Enphase Energy
$69.05 /

+7.84 (+12.81%)

ENPH Enphase Energy
$69.05 /

+7.84 (+12.81%)

ENPH Enphase Energy
$69.05 /

+7.84 (+12.81%)

Hot Stocks
New York Times sees Q3 total subscription revenues up 10% » 07:12
08/05/20
08/05
07:12
08/05/20
07:12
NYT

New York Times

$46.81 /

+0.93 (+2.03%)

Sees Q3 total advertising…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

06/22/20 Dawson James
Channel checks dispute NY Times' COVID contention, says Dawson James
06/15/20 JPMorgan
New York Times price target raised to $50 from $42 at JPMorgan
06/12/20 Loop Capital
News Corp price target raised to $18 from $16 at Loop Capital
04/23/20 Evercore ISI
New York Times downgraded to In Line from Outperform at Evercore ISI
NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

Recommendations
Evolent Health price target raised to $20 from $15 at Truist » 07:11
08/05/20
08/05
07:11
08/05/20
07:11
EVH

Evolent Health

$12.75 /

+0.755 (+6.29%)

Truist analyst Sandy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$12.75 /

+0.755 (+6.29%)

EVH Evolent Health
$12.75 /

+0.755 (+6.29%)

07:00 Today Cantor Fitzgerald
Evolent Health price target raised to $13 from $10 at Cantor Fitzgerald
07/06/20 KeyBanc
Evolent Health downgraded to Sector Weight from Overweight at KeyBanc
07/06/20 KeyBanc
Evolent Health downgraded to Sector Weight from Overweight at KeyBanc
06/26/20 JPMorgan
Evolent Health price target lowered to $8 from $11 at JPMorgan
EVH Evolent Health
$12.75 /

+0.755 (+6.29%)

EVH Evolent Health
$12.75 /

+0.755 (+6.29%)

Earnings
Charles River reports Q2 EPS $1.58, consensus $1.26 » 07:11
08/05/20
08/05
07:11
08/05/20
07:11
CRL

Charles River

$203.78 /

-3.69 (-1.78%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRL Charles River
$203.78 /

-3.69 (-1.78%)

CRL Charles River
$203.78 /

-3.69 (-1.78%)

07/21/20 UBS
Charles River price target raised to $236 from $200 at UBS
07/01/20 BofA
Charles River upgraded to Buy from Neutral at BofA
07/01/20 BofA
Charles River upgraded to Buy from Neutral at BofA
05/26/20 Argus
Charles River price target raised to $190 from $150 at Argus
CRL Charles River
$203.78 /

-3.69 (-1.78%)

Earnings
GasLog Partners reports Q2 EPS 44c, consensus 28c » 07:11
08/05/20
08/05
07:11
08/05/20
07:11
GLOP

GasLog Partners

$3.94 /

+0.02 (+0.51%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

04/30/20 BTIG
GasLog Partners cut to Neutral at BTIG on valuation
04/30/20 BTIG
GasLog Partners downgraded to Neutral from Buy at BTIG
02/07/20 Citi
GasLog Partners downgraded to Neutral from Buy at Citi
02/07/20 Citi
GasLog downgraded to Neutral from Buy at Citi
GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

GLOP GasLog Partners
$3.94 /

+0.02 (+0.51%)

Earnings
InMode sees FY20 revenue $156M-$160M, consensus $143.04M » 07:11
08/05/20
08/05
07:11
08/05/20
07:11
INMD

InMode

$32.92 /

-0.53 (-1.58%)

InMode said, "We…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INMD InMode
$32.92 /

-0.53 (-1.58%)

INMD InMode
$32.92 /

-0.53 (-1.58%)

02/19/20 Barclays
InMode price target raised to $48 from $45 at Barclays
01/28/20 Baird
InMode price target raised to $55 from $45 at Baird
11/06/19 Barclays
InMode price target raised to $45 from $27 at Barclays
11/06/19 Baird
InMode price target raised to $45 from $27 at Baird
INMD InMode
$32.92 /

-0.53 (-1.58%)

  • 08
    Aug
INMD InMode
$32.92 /

-0.53 (-1.58%)

INMD InMode
$32.92 /

-0.53 (-1.58%)

Earnings
New York Times reports Q2 adj. EPS 18c, consensus 1c » 07:10
08/05/20
08/05
07:10
08/05/20
07:10
NYT

New York Times

$46.81 /

+0.93 (+2.03%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

06/22/20 Dawson James
Channel checks dispute NY Times' COVID contention, says Dawson James
06/15/20 JPMorgan
New York Times price target raised to $50 from $42 at JPMorgan
06/12/20 Loop Capital
News Corp price target raised to $18 from $16 at Loop Capital
04/23/20 Evercore ISI
New York Times downgraded to In Line from Outperform at Evercore ISI
NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

NYT New York Times
$46.81 /

+0.93 (+2.03%)

Earnings
InMode reports Q2 adjusted EPS 24c, consensus (6c) » 07:10
08/05/20
08/05
07:10
08/05/20
07:10
INMD

InMode

$32.92 /

-0.53 (-1.58%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INMD InMode
$32.92 /

-0.53 (-1.58%)

INMD InMode
$32.92 /

-0.53 (-1.58%)

02/19/20 Barclays
InMode price target raised to $48 from $45 at Barclays
01/28/20 Baird
InMode price target raised to $55 from $45 at Baird
11/06/19 Barclays
InMode price target raised to $45 from $27 at Barclays
11/06/19 Baird
InMode price target raised to $45 from $27 at Baird
INMD InMode
$32.92 /

-0.53 (-1.58%)

  • 08
    Aug
INMD InMode
$32.92 /

-0.53 (-1.58%)

INMD InMode
$32.92 /

-0.53 (-1.58%)

Earnings
Middleby reports Q2 adj. EPS 55c, consensus 41c » 07:10
08/05/20
08/05
07:10
08/05/20
07:10
MIDD

Middleby

$85.68 /

+1.74 (+2.07%)

Reports Q2 revenue $472M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MIDD Middleby
$85.68 /

+1.74 (+2.07%)

MIDD Middleby
$85.68 /

+1.74 (+2.07%)

07/17/20 Citi
Middleby price target raised to $90 from $85 at Citi
06/29/20
Fly Intel: Top five analyst upgrades
06/29/20 KeyBanc
Middleby upgraded to Overweight at KeyBanc on valuation, secular dynamics
06/29/20 KeyBanc
Middleby upgraded to Overweight from Sector Weight at KeyBanc
MIDD Middleby
$85.68 /

+1.74 (+2.07%)

MIDD Middleby
$85.68 /

+1.74 (+2.07%)

Earnings
Intec Pharma reports Q2 EPS (5c), consensus (5c) » 07:09
08/05/20
08/05
07:09
08/05/20
07:09
NTEC

Intec Pharma

$0.43 /

+0.017 (+4.11%)

CEO Jeffrey Meckler said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTEC Intec Pharma
$0.43 /

+0.017 (+4.11%)

11/14/19 Roth Capital
Intec Pharma may pursue partnership after failed trial, says Roth Capital
10/11/19 Roth Capital
Intec Pharma downgraded to Neutral from Buy at Roth Capital
08/07/19 H.C. Wainwright
Intec Pharma downgraded to Neutral from Buy at H.C. Wainwright
NTEC Intec Pharma
$0.43 /

+0.017 (+4.11%)

  • 31
    Jan
NTEC Intec Pharma
$0.43 /

+0.017 (+4.11%)

Earnings
Surgery Partners reports Q2 EPS (86c), consensus (69c) » 07:09
08/05/20
08/05
07:09
08/05/20
07:09
SGRY

Surgery Partners

$15.99 /

+0.55 (+3.56%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGRY Surgery Partners
$15.99 /

+0.55 (+3.56%)

04/27/20 Benchmark
Surgery Partners upgraded to Buy on faster recovery timeline at Benchmark
04/27/20 Benchmark
Surgery Partners upgraded to Buy from Hold at Benchmark
04/21/20
Envision bankruptcy report has limited read-throughs, says Benchmark
03/24/20 RBC Capital
Surgery Partners price target lowered to $14 from $19 at RBC Capital
SGRY Surgery Partners
$15.99 /

+0.55 (+3.56%)

SGRY Surgery Partners
$15.99 /

+0.55 (+3.56%)

Recommendations
Mallinckrodt price target lowered to $2 from $4 at BMO Capital » 07:08
08/05/20
08/05
07:08
08/05/20
07:08
MNK

Mallinckrodt

$1.62 /

-0.64 (-28.32%)

BMO Capital analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNK Mallinckrodt
$1.62 /

-0.64 (-28.32%)

MNK Mallinckrodt
$1.62 /

-0.64 (-28.32%)

08/04/20 Piper Sandler
Mallinckrodt downgraded to Underweight from Neutral at Piper Sandler
07/14/20 BMO Capital
Briefing docs suggest AdComm 'challenges' for Mallinckrodt, says BMO Capital
06/17/20 Citi
Sell Mallinckrodt, buy Endo with opioid risk coming back, says Citi
05/19/20 JPMorgan
Mallinckrodt downgraded to Underweight on unclear turnaround at JPMorgan
MNK Mallinckrodt
$1.62 /

-0.64 (-28.32%)

MNK Mallinckrodt
$1.62 /

-0.64 (-28.32%)

MNK Mallinckrodt
$1.62 /

-0.64 (-28.32%)

MNK Mallinckrodt
$1.62 /

-0.64 (-28.32%)

Earnings
Extreme Networks sees Q1 adjusted EPS 1c-4c, consensus 0c » 07:08
08/05/20
08/05
07:08
08/05/20
07:08
EXTR

Extreme Networks

$4.75 /

+0.17 (+3.71%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXTR Extreme Networks
$4.75 /

+0.17 (+3.71%)

EXTR Extreme Networks
$4.75 /

+0.17 (+3.71%)

07/21/20 B. Riley FBR
HP Enterprise deal shows Extreme Networks undervalued, says B. Riley FBR
07/15/20 B. Riley FBR
B. Riley starts Extreme Networks at Buy, calls 'best pure networking play'
07/14/20 B. Riley FBR
Extreme Networks initiated with a Buy at B. Riley FBR
06/04/20 Lake Street
Extreme Networks price target raised to $5 from $4 at Lake Street
EXTR Extreme Networks
$4.75 /

+0.17 (+3.71%)

EXTR Extreme Networks
$4.75 /

+0.17 (+3.71%)

Earnings
Reynolds Consumer Products backs FY20 adj. EPS view $1.85-$1.92, consensus $1.90  07:08
08/05/20
08/05
07:08
08/05/20
07:08
REYN

Reynolds Consumer Products

$34.52 /

+0.11 (+0.32%)

 
ShowHide Related Items >><<
REYN Reynolds Consumer Products
$34.52 /

+0.11 (+0.32%)

07/16/20 JPMorgan
Reynolds Consumer Products price target raised to $38 from $37 at JPMorgan
05/15/20 Citi
Reynolds Consumer Products price target raised to $41 from $33 at Citi
02/26/20 Citi
Reynolds Consumer Products initiated with a Buy at Citi
02/25/20 Evercore ISI
Reynolds Consumer Products initiated with an Outperform at Evercore ISI
REYN Reynolds Consumer Products
$34.52 /

+0.11 (+0.32%)

  • 31
    Jan
REYN Reynolds Consumer Products
$34.52 /

+0.11 (+0.32%)

Hot Stocks
Wayfair reports 26M active customers as of June 30 » 07:07
08/05/20
08/05
07:07
08/05/20
07:07
W

Wayfair

$290.80 /

+3.21 (+1.12%)

Wayfair said in its Q2…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
W Wayfair
$290.80 /

+3.21 (+1.12%)

W Wayfair
$290.80 /

+3.21 (+1.12%)

07/29/20 Credit Suisse
Wayfair price target raised to $260 from $198 at Credit Suisse
07/27/20 Wells Fargo
Wayfair price target raised to $225 from $215 at Wells Fargo
07/24/20 Piper Sandler
Wayfair price target raised to $275 from $225 at Piper Sandler
07/20/20 Goldman Sachs
Wayfair price target raised to $260 from $220 at Goldman Sachs
W Wayfair
$290.80 /

+3.21 (+1.12%)

W Wayfair
$290.80 /

+3.21 (+1.12%)

W Wayfair
$290.80 /

+3.21 (+1.12%)

W Wayfair
$290.80 /

+3.21 (+1.12%)

Earnings
Bicycle Therapeutics reports Q2 EPS (67c), consensus (48c) » 07:07
08/05/20
08/05
07:07
08/05/20
07:07
BCYC

Bicycle Therapeutics

$15.81 /

+0.31 (+2.00%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCYC Bicycle Therapeutics
$15.81 /

+0.31 (+2.00%)

BCYC Bicycle Therapeutics
$15.81 /

+0.31 (+2.00%)

06/11/20 Oppenheimer
Oppenheimer starts 'revolutionary' Bicycle Therapeutics at Outperform
06/11/20 Oppenheimer
Bicycle Therapeutics initiated with an Outperform at Oppenheimer
04/17/20
Fly Intel: Top five analyst initiations
04/17/20 H.C. Wainwright
Bicycle Therapeutics initiated with a Buy at H.C. Wainwright
BCYC Bicycle Therapeutics
$15.81 /

+0.31 (+2.00%)

BCYC Bicycle Therapeutics
$15.81 /

+0.31 (+2.00%)

Earnings
Broadwind Energy reports Q2 EPS 3c, consensus 2c » 07:07
08/05/20
08/05
07:07
08/05/20
07:07
BWEN

Broadwind

$4.69 /

+0.075 (+1.63%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BWEN Broadwind
$4.69 /

+0.075 (+1.63%)

BWEN Broadwind
$4.69 /

+0.075 (+1.63%)

07/22/20 H.C. Wainwright
Wind 'a big beneficiary' in NY renewable energy expansion, says H.C. Wainwright
07/07/20 Craig-Hallum
Broadwind initiated with a Buy at Craig-Hallum
06/16/20 H.C. Wainwright
Broadwind initiated with a Buy at H.C. Wainwright
BWEN Broadwind
$4.69 /

+0.075 (+1.63%)

BWEN Broadwind
$4.69 /

+0.075 (+1.63%)

Recommendations
BioMarin shares can re-rate further despite 42% rally, says Cantor Fitzgerald » 07:07
08/05/20
08/05
07:07
08/05/20
07:07
BMRN

BioMarin

$119.65 /

-2.44 (-2.00%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMRN BioMarin
$119.65 /

-2.44 (-2.00%)

BMRN BioMarin
$119.65 /

-2.44 (-2.00%)

08/04/20 Piper Sandler
BioMarin price target raised to $133 from $120 at Piper Sandler
07/24/20 Baird
BioMarin price target raised to $140 from $125 at Baird
07/08/20 Morgan Stanley
Morgan Stanley cuts BioMarin to Equal Weight with pipeline seen better priced in
07/08/20 Morgan Stanley
BioMarin downgraded to Equal Weight from Overweight at Morgan Stanley
BMRN BioMarin
$119.65 /

-2.44 (-2.00%)

BMRN BioMarin
$119.65 /

-2.44 (-2.00%)

BMRN BioMarin
$119.65 /

-2.44 (-2.00%)

Earnings
Extreme Networks reports Q4 adjusted EPS 3c, consensus (3c) » 07:07
08/05/20
08/05
07:07
08/05/20
07:07
EXTR

Extreme Networks

$4.75 /

+0.17 (+3.71%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXTR Extreme Networks
$4.75 /

+0.17 (+3.71%)

EXTR Extreme Networks
$4.75 /

+0.17 (+3.71%)

07/21/20 B. Riley FBR
HP Enterprise deal shows Extreme Networks undervalued, says B. Riley FBR
07/15/20 B. Riley FBR
B. Riley starts Extreme Networks at Buy, calls 'best pure networking play'
07/14/20 B. Riley FBR
Extreme Networks initiated with a Buy at B. Riley FBR
06/04/20 Lake Street
Extreme Networks price target raised to $5 from $4 at Lake Street
EXTR Extreme Networks
$4.75 /

+0.17 (+3.71%)

EXTR Extreme Networks
$4.75 /

+0.17 (+3.71%)

Earnings
Reynolds Consumer Products reports Q2 adj. EPS 55c, consensus 52c » 07:06
08/05/20
08/05
07:06
08/05/20
07:06
REYN

Reynolds Consumer Products

$34.52 /

+0.11 (+0.32%)

Reports Q2 revenue $822M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REYN Reynolds Consumer Products
$34.52 /

+0.11 (+0.32%)

07/16/20 JPMorgan
Reynolds Consumer Products price target raised to $38 from $37 at JPMorgan
05/15/20 Citi
Reynolds Consumer Products price target raised to $41 from $33 at Citi
02/26/20 Citi
Reynolds Consumer Products initiated with a Buy at Citi
02/25/20 Evercore ISI
Reynolds Consumer Products initiated with an Outperform at Evercore ISI
REYN Reynolds Consumer Products
$34.52 /

+0.11 (+0.32%)

  • 31
    Jan
REYN Reynolds Consumer Products
$34.52 /

+0.11 (+0.32%)

Earnings
Wayfair reports Q2 EPS $3.13, consensus $1.04 » 07:06
08/05/20
08/05
07:06
08/05/20
07:06
W

Wayfair

$290.80 /

+3.21 (+1.12%)

Reports Q2 revenue $4.3B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
W Wayfair
$290.80 /

+3.21 (+1.12%)

W Wayfair
$290.80 /

+3.21 (+1.12%)

07/29/20 Credit Suisse
Wayfair price target raised to $260 from $198 at Credit Suisse
07/27/20 Wells Fargo
Wayfair price target raised to $225 from $215 at Wells Fargo
07/24/20 Piper Sandler
Wayfair price target raised to $275 from $225 at Piper Sandler
07/20/20 Goldman Sachs
Wayfair price target raised to $260 from $220 at Goldman Sachs
W Wayfair
$290.80 /

+3.21 (+1.12%)

W Wayfair
$290.80 /

+3.21 (+1.12%)

W Wayfair
$290.80 /

+3.21 (+1.12%)

W Wayfair
$290.80 /

+3.21 (+1.12%)

Earnings
Perrigo backs FY20 adjusted EPS view $3.95-$4.15, consensus $4.06 » 07:05
08/05/20
08/05
07:05
08/05/20
07:05
PRGO

Perrigo

$55.06 /

+0.35 (+0.64%)

Backs FY20 revenue growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRGO Perrigo
$55.06 /

+0.35 (+0.64%)

PRGO Perrigo
$55.06 /

+0.35 (+0.64%)

06/16/20 JPMorgan
Perrigo tax dispute well reflected in shares, says JPMorgan
06/08/20 SVB Leerink
Perrigo price target raised to $63 from $55 at SVB Leerink
04/17/20
Argus cuts Perrigo to Hold on rising credit risk, generic price-fixing lawsuit
04/17/20 Argus
Perrigo downgraded to Hold from Buy at Argus
PRGO Perrigo
$55.06 /

+0.35 (+0.64%)

PRGO Perrigo
$55.06 /

+0.35 (+0.64%)

PRGO Perrigo
$55.06 /

+0.35 (+0.64%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.